Compass Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Compass Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Compass Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Compass Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $97k | 62k | 1.56 |
| 2023-09-30 | $124k | 63k | 1.97 |
| 2023-06-30 | $226k | 71k | 3.18 |
| 2023-03-31 | $999 | 407 | 2.46 |
| 2021-12-31 | $75k | 24k | 3.16 |